Curaleaf Holdings, Inc.

General ticker "CURLF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $5.6B (TTM average)

Curaleaf Holdings, Inc. follows the US Stock Market performance with the rate: 46.0%.

Estimated limits based on current volatility of 4.8%: low 9.94$, high 10.94$

Factors to consider:

  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [5.79$, 11.91$]
  • 2026-12-31 to 2027-12-31 estimated range: [4.41$, 9.45$]

Financial Metrics affecting the CURLF estimates:

  • Positive: with PPE of -12.4 at the end of fiscal year the price was neutral
  • Positive: -5.39 < Operating profit margin, % of 2.01
  • Negative: negative Net income
  • Positive: -4.41 < Investing cash flow per share per price, % of -3.16
  • Positive: 19.24 < Shareholder equity ratio, % of 26.58 <= 42.59
  • Positive: Inventory ratio change, % of -14.59 <= -0.75

Similar symbols

Short-term CURLF quotes

Long-term CURLF plot with estimates

Financial data

YTD 2025-12-31
Operating Revenue $1,290.33MM
Operating Expenses $1,264.44MM
Operating Income $25.90MM
Non-Operating Income $-105.48MM
Interest Expense $102.59MM
Income(Loss) $-79.58MM
Taxes $125.85MM
Net Income(Loss)* $-235.12MM
Stockholders Equity $754.97MM
Assets $2,840.14MM
Operating Cash Flow $140.35MM
Capital expenditure $64.55MM
Investing Cash Flow $-71.80MM
Financing Cash Flow $-74.78MM
Earnings Per Share** $-0.93

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.